A chaotic CDC meeting under RFK Jr.’s influence raises concerns about possible vaccine schedule changes.
Story Highlights
- RFK Jr. influences CDC’s Advisory Committee on Immunization Practices (ACIP).
- Speculation arises about adopting Denmark’s vaccine schedule.
- Hepatitis B vaccination vote postponed amid confusion and anti-vaccine rhetoric.
- Concerns grow about potential public health impacts of vaccine schedule changes.
RFK Jr.’s Influence on Vaccine Policy
In 2025, Robert F. Kennedy Jr., as Secretary of Health and Human Services, appointed members to the CDC’s Advisory Committee on Immunization Practices (ACIP) who share his skepticism about vaccines. This shift has led to speculation about a possible overhaul of the U.S. childhood vaccine schedule to align more closely with Denmark’s, which administers fewer early vaccines.
This speculation intensified during a chaotic ACIP meeting in December 2025, where discussions included comparisons of international vaccine schedules. Critics argue that these changes could undermine public trust in vaccines and potentially lead to a resurgence of preventable diseases.
The meeting, marked by confusion and anti-vaccine points, saw a postponement in the vote to scale back hepatitis B vaccinations for infants. This delay was attributed to last-minute changes in wording and procedural missteps, sparking concerns among public health experts and advocates.
Impact of Vaccine Schedule Changes
Denmark’s vaccine schedule is often cited for its minimal approach, delaying certain vaccines like hepatitis B for infants unless they are at high risk. In contrast, the U.S. schedule has been credited with dramatically reducing cases of hepatitis B by vaccinating infants at birth.
Critics of the potential changes argue that scaling back the birth dose of hepatitis B vaccines could result in increased rates of the disease, especially among newborns who are at the highest risk of infection from maternal transmission. Public health advocates warn that adopting a lighter schedule without new safety data could reverse years of progress in combating vaccine-preventable diseases.
Reactions from Health Experts
Health experts and advocates have voiced strong objections to the proposed changes, emphasizing the importance of evidence-based vaccine policies. Dr. Grant Paulsen of the Pediatric Infectious Diseases Society questioned the rationale behind revisiting established vaccine schedules without new data. Voices for Vaccines, an advocacy group, highlighted the risks of delaying the hepatitis B birth dose, which provides critical early protection.
Amid growing concerns, the Vaccine for Children (VFC) program and Centers for Medicare and Medicaid Services (CMS) have assured that funding for the hepatitis B vaccine will continue, regardless of potential schedule changes. However, the ongoing debate has underscored the need for rigorous scientific evaluation and transparent decision-making in vaccine policy.
